Sepsis and shock detection software takes leap with US approval
By
Aaron Dorman
Jun 28, 2023
The US Food and Drug Administration approved use of AI-powered sepsis detection software last week, part of a slew of recent innovations from South Korea.
Continuous meropenem no benefit in critically ill patients with sepsis
Jun 22, 2023
No improvement was seen in the composite of all-cause mortality and the emergence of pandrug- or extensively drug-resistant bacteria.
Hydrocortisone does not reduce 90-day mortality in septic shock
May 31, 2023
A small reduction in mortality was seen with use of hydrocortisone with fludrocortisone.
Hydrocortisone plus fludrocortisone superior for septic shock
Apr 13, 2023
Compared with hydrocortisone alone, the combo significantly cuts the risk for in-hospital death or hospice discharge.
Cardiovascular hospitalization increased after sepsis hospitalization
Feb 01, 2023
“Professionals need to be aware that people who have previously had sepsis are at very high risk for cardiovascular events,” an author said.
Early warning system can identify sepsis patients
Aug 03, 2022
Patients whose alert was confirmed by a provider within three hours had a reduced in-hospital mortality rate.
IV vitamin C increases risk for death, organ failure in sepsis
Jun 17, 2022
The risk increased with intravenous vitamin C versus placebo for adults with sepsis in the ICU receiving vasopressor therapy.
Greater nurse staffing tied to better sepsis outcomes
Jun 01, 2022
An increase in registered nurse hours per patient day was associated with a 3% decrease in 60-day mortality.
These medical innovations are good news for aging adults
By
Lois A. Bowers
Mar 07, 2022
Sepsis, prostate cancer, high cholesterol, type 2 diabetes, hypertension. These are some of the conditions that will benefit from medical advancements noted on the Cleveland Clinic’s recently announced...
Scientists report ‘rogue antibodies’ behind severe clotting with COVID-19
Feb 18, 2022
The study authors suggest that future research assess the potential benefits of screening COVID-19 patients for antiphospholipids and other autoantibodies.